Aldeyra Therapeutics, Inc.ALDXNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank86
5Y CAGR+3.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+3.0%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$65115.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$56221.00-41.6%
2019$96305.00+35.6%
2018$71003.00+87.6%
2017$37849.00-
2016$0.00-